D
Verrica Pharmaceuticals Inc. VRCA
$5.16 -$0.07-1.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 44.09% 18.27% -14.31% -75.92% -271.06%
Total Depreciation and Amortization -8.99% 16.74% 51.79% 50.37% 36.60%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -53.62% -41.39% -30.28% -3.53% 218.02%
Change in Net Operating Assets -2,831.65% -100.72% -79.44% 140.06% -108.36%
Cash from Operations 27.86% 0.51% -57.94% -104.55% -429.73%
Capital Expenditure 94.72% 92.31% 92.54% -26.37% -42.25%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 97.36% 94.59% 94.75% -103.84% -103.46%
Total Debt Issued -- -- -- -100.00% --
Total Debt Repaid -2,372.75% -2,595.53% -3,917.39% -- 99.19%
Issuance of Common Stock 25,638.96% 994,600.00% 31.29% -99.49% -99.73%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 98.48% 3.96% -547.73% -654.34% -958.93%
Cash from Financing -27.86% -20.66% -49.16% -102.32% 220.09%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 28.76% -75.65% -165.82% -218.35% -339.03%